Why COVID vaccines for young children (5–11 years) are not essential at this moment in time?
Journal of Pharmaceutical Policy and Practice, 2022 The Joint Committee on Vaccination and Immunisation (JCVI) in UK has recently advised that COVID vaccines in 5–11-year-old children is non-essential. This has created an outrage among some healthcare professionals who believed a mandatory vaccination ...
Hamid A. Merchant
doaj +1 more source
Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era
Expert Review of Vaccines, 2023 Introduction The Omicron BA.1 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and subsequent sub-lineages exhibit partial escape from neutralizing antibodies elicited by vaccines containing or encoding wild-type spike protein.
Shanti Pather +3 more
doaj +1 more source
Concomitant Peripheral and Pulmonary Arterial Thromboembolism 35 Days After SARS-CoV-2 mRNA Vaccine
Cam & Sakura Medical Journal, 2023 Although thromboembolism after ChAdOx1 vaccine has been extensively reported, this association was rarely reported after vaccination with BNT162b2. We present the case of an otherwise healthy patient who developed concomitant acute limb ischemia and ...
Ahmet Can Topçu +3 more
doaj +1 more source
Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
Human Vaccines & Immunotherapeutics, 2023 This open-labeled non-inferiority trial evaluated immunogenicity and reactogenicity of heterologous and homologous COVID-19 vaccination schedules in pregnant Thai women.
Chenchit Chayachinda +16 more
doaj +1 more source
Safety and efficacy of RNA vaccines: State of the art
Медицинская иммунология, 2021 This review describes principles of action and the method of delivery of mRNA molecules into cells, as well as some of developed RNA vaccines and the results obtained in their study, though they have not been authorized for use yet.
A. V. Blagov +3 more
doaj +1 more source
Is a single COVID-19 vaccine dose enough in convalescents ?
Human Vaccines & Immunotherapeutics, 2021 SARS-CoV-2 has infected more than 122 million persons worldwide. Most currently licensed COVID-19 vaccines require a two-dose course and many health systems are on a shortage of doses.
Daniele Focosi +2 more
doaj +1 more source
Branch Retinal Vein Occlusion after Messenger RNA-Based COVID-19 Vaccine
Case Reports in Ophthalmology, 2022 Two days after the second dose of the messenger RNA-based COVID-19 vaccine (BNT162b2), a healthy 38-year-old man developed branch retinal vein occlusion (BRVO) in his left eye (OS).
Kazunobu Sugihara +2 more
doaj +1 more source
Safety and BNT162b2 mRNA COVID-19 vaccination.
Acta bio-medica : Atenei Parmensis, 2021 n/a.
Joob, Beuy, Wiwanitkit, Viroj
openaire +2 more sources
Side Effects Related to BNT162b2 and CoronaVac Vaccine Requiring Emergency Department Visit
Avicenna Journal of Medicine, 2022 Background Currently, the most effective method in the fight against coronavirus disease 2019 (COVID-19) is vaccination against the disease. However, there are hesitations among society concerning the safety and side effects of COVID-19 vaccines.
Erdal Yavuz +6 more
doaj +1 more source
Lymphocyte levels following COVID-19 vaccine BNT162b2
, 2021 Introduction: The BNT162b2 vaccine has been shown to be effective in reducing the incidence, severity and mortality of Coronavirus Disease 2019 (COVID-19).
Oren Miron, Nadav Davidovitch
core +1 more source